Skip to main content

Dr. Nan Chen

Medical Oncology (Medical Oncology Physician)

5841 S Maryland Ave
Chicago, IL 60637

Who else practices at this address →

Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas

Call (888) 824-0200

  • Medicare participating

At a glance

Medical school
New York Medical College (2015)
Years since graduation
11
In the NPI registry since
2015
Medicare patients seen, 2024
168

Licensed in Illinois since 2021, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2015Medical school: New York Medical College
  • 2015Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    IL license 036156991 (first issued 2021; active) · IN license 01091761A

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
168
Services billed
685
Patients’ average age
72
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes16278
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes12137
Established patient office or other outpatient visit, 40-54 minutes3923
Established patient office or other outpatient visit, 20-29 minutes3531
New patient office or other outpatient visit, 60-74 minutes3232
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2828
Hospital discharge day management, 30 minutes or less2120

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 7 companies reported 24 payments worth $13,845 in total to this clinician.

By company
Genentech USA, Inc.$4,686
AstraZeneca Pharmaceuticals LP$3,309
Tersera Therapeutics LLC$3,280
Daiichi Sankyo Inc.$1,566
Gilead Sciences, Inc.$638
Novartis Pharmaceuticals Corporation$277
Stemline Therapeutics Inc.$88.84
By type
Consulting Fee$11,393
Food and Beverage$920
Speaking at a medical education program$843
Travel and Lodging$490
Long term medical supply or device loan$199

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 26, 2025Tersera Therapeutics LLC
Sep 26, 2025
Consulting Fee
Zoladex · Oncology
$3,000
Jul 10, 2025Genentech USA, Inc.
Jul 10, 2025
Consulting Fee
Herceptin; Perjeta; Phesgo · BioOncology
$2,731
Jun 16, 2025AstraZeneca Pharmaceuticals LP
Jun 16, 2025
Consulting Fee$1,675
Nov 6, 2025Genentech USA, Inc.
Nov 6, 2025
Consulting Fee$1,230
Apr 25, 2025Daiichi Sankyo Inc.
Apr 25, 2025
Consulting Fee
DATROWAY · ONCOLOGY
$1,173
Feb 28, 2025AstraZeneca Pharmaceuticals LP
Feb 28, 2025
Speaking at a medical education program$843
Apr 8, 2025AstraZeneca Pharmaceuticals LP
Apr 8, 2025
Consulting Fee$670
May 8, 2025Gilead Sciences, Inc.
May 8, 2025
Consulting Fee
Trodelvy · ONC
Company’s description;4146994;VEM US;12663617
$580
Jul 10, 2025Genentech USA, Inc.
Jul 10, 2025
Travel and Lodging
Herceptin; Perjeta; Phesgo · BioOncology · travel to New York City, NY · in-kind
$375
Jul 15, 2025Daiichi Sankyo Inc.
Jul 15, 2025
Consulting Fee
DATROWAY · ONCOLOGY
$335
All 14 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 30, 2025Novartis Pharmaceuticals Corporation
Dec 30, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$99.70
Nov 26, 2025Novartis Pharmaceuticals Corporation
Nov 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$99.70
Nov 6, 2025Genentech USA, Inc.
Nov 6, 2025
Consulting Fee$1,230
Sep 26, 2025Tersera Therapeutics LLC
Sep 26, 2025
Consulting Fee
Zoladex · Oncology
$3,000
Jul 15, 2025Daiichi Sankyo Inc.
Jul 15, 2025
Consulting Fee
DATROWAY · ONCOLOGY
$335
Jul 10, 2025Genentech USA, Inc.
Jul 10, 2025
Consulting Fee
Herceptin; Perjeta; Phesgo · BioOncology
$2,731
Jul 10, 2025Genentech USA, Inc.
Jul 10, 2025
Travel and Lodging
Herceptin; Perjeta; Phesgo · BioOncology · travel to New York City, NY · in-kind
$375
Jul 10, 2025Genentech USA, Inc.
Jul 10, 2025
Travel and Lodging
Herceptin; Perjeta; Phesgo · BioOncology · travel to New York City, NY
$106
Jun 16, 2025AstraZeneca Pharmaceuticals LP
Jun 16, 2025
Consulting Fee$1,675
May 8, 2025Gilead Sciences, Inc.
May 8, 2025
Consulting Fee
Trodelvy · ONC
Company’s description;4146994;VEM US;12663617
$580
Apr 25, 2025Daiichi Sankyo Inc.
Apr 25, 2025
Consulting Fee
DATROWAY · ONCOLOGY
$1,173
Apr 8, 2025AstraZeneca Pharmaceuticals LP
Apr 8, 2025
Consulting Fee$670
Feb 28, 2025AstraZeneca Pharmaceuticals LP
Feb 28, 2025
Speaking at a medical education program$843
Feb 28, 2025AstraZeneca Pharmaceuticals LP
Feb 28, 2025
Travel and Lodging
travel to Chicago, IL
$8.50

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Illinois →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $259,608 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Medical Oncology clinicians in Chicago

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 4, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1558749887. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.